- World rank, 2022–2025
- #24,588 of 28,054 · #35,978 all time
- Rank in United States
- #3,700 of 4,192
- Research works
- 162 ▲ 264% vs 2013–17
- Citations
- 1.7k 10.2 per fractional work
- Top-10% rate
- 6.3% record average 16.5%
- Open access
- 65% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 6.8×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 6.8×
- Economics, Econometrics and Finance 4.9×
- Biochemistry, Genetics and Molecular Biology 2.6×
- Medicine 2.6×
- Immunology and Microbiology 2.5×
- Chemistry 1.5×
- Neuroscience 1.4×
- Mathematics 0.9×
- Nursing 0.8×
- Engineering 0.7×
- Materials Science 0.4×
- Physics and Astronomy 0.4×
- Energy 0.2×
- Psychology 0.2×
- Computer Science 0.1×
Who are the top researchers at Novocure (United States)?
Ranked on the composite score, Uri Weinberg, Moshe Giladi and Mijal Munster lead among researchers whose main affiliation is Novocure (United States).
- 1 Uri Weinberg United States · #724,613 worldwide 79 citations · 36 works
- 2 Moshe Giladi United States · #1,331,998 worldwide 23 citations · 42 works
- 3 Mijal Munster United States · #1,628,875 worldwide 5 citations · 16 works
Which keywords describe research at Novocure (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Radiotherapy, Molecular Classification, Glioblastoma, Temozolomide, Clinical Trials, Targeted Therapy and Chemotherapy.
- Proton Therapy
- Genomic Analysis
- Biological Activity
- Metastasis
- Tumor Microenvironment
- Feature Extraction
- Bacterial Therapy
- Financial Toxicity
- Microfluidic Devices
- Bioprinting
- Tissue Engineering
- Health Utility Measures
- Economic Evaluation
- Regenerative Medicine
- Tumor Targeting
- EGFR Mutations
- Chemotherapy
- Clinical Trials
- Molecular Classification
- Radiotherapy
- Immunotherapy
- Glioblastoma
- Temozolomide
- Targeted Therapy
- ALK Inhibitors
- Quality of Life
- Machine Learning
- Cost-effectiveness Analysis
- Gene Therapy
- Cancer
- Cancer Treatment
- Medicinal Chemistry
- Cost of Care
- Arginine Deprivation
- Biomarkers
- Medical Imaging
- Clinical Applications
- Precision Medicine
- Dosimetry
- Particle Therapy
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Immunotherapy14▲ 32×10 topics
- Radiotherapy11▲ 44×4 topics
- Glioblastoma8▲ 193×1 topic
- Molecular Classification8▲ 87×2 topics
- Temozolomide8▲ 193×1 topic
- Clinical Trials7▲ 16×5 topics
- Targeted Therapy6▲ 43×4 topics
- Chemotherapy5▲ 11×10 topics
- ALK Inhibitors4▲ 106×1 topic
- EGFR Mutations4▲ 106×1 topic
- Quality of Life4▲ 4.3×2 topics
- Tumor Targeting4▲ 33×3 topics
- Machine Learning4▲ 1.75×4 topics
- Regenerative Medicine4▲ 23×3 topics
- Cost-effectiveness Analysis4▲ 65×1 topic
- Economic Evaluation4▲ 46×2 topics
- Gene Therapy4▲ 30×4 topics
- Health Utility Measures4▲ 65×1 topic
- Cancer3▲ 4.1×11 topics
- Tissue Engineering3▲ 8.2×3 topics
- Cancer Treatment3▲ 20×6 topics
- Bioprinting3▲ 78×1 topic
- Medicinal Chemistry3▲ 17×5 topics
- Microfluidic Devices3▲ 39×1 topic
- Cost of Care3▲ 139×1 topic
- Financial Toxicity3▲ 139×1 topic
- Arginine Deprivation2▲ 108×1 topic
- Bacterial Therapy2▲ 108×1 topic
- Biomarkers2▲ 4.6×4 topics
- Feature Extraction2▲ 7.0×2 topics
- Medical Imaging2▲ 6.3×2 topics
- Tumor Microenvironment2▲ 7.3×4 topics
- Clinical Applications2▲ 48×2 topics
- Metastasis2▲ 9.1×3 topics
- Precision Medicine2▲ 5.8×2 topics
- Biological Activity2▲ 52×2 topics
- Dosimetry2▲ 34×2 topics
- Genomic Analysis2▲ 9.4×3 topics
- Particle Therapy2▲ 99×1 topic
- Proton Therapy2▲ 99×1 topic
Which research topics does Novocure (United States) publish most on?
By volume in 2022–2025: Glioma Diagnosis and Treatment, Lung Cancer Treatments and Mutations, Health Systems, Economic Evaluations, Quality of Life and 3D Printing in Biomedical Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Glioma Diagnosis and Treatment Genetics 8 works
- 2 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 4 works
- 3 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 4 works
- 4 3D Printing in Biomedical Research Biomedical Engineering 3 works
- 5 Economic and Financial Impacts of Cancer Economics and Econometrics 3 works
- 6 Cancer Research and Treatments Biotechnology 2 works
- 7 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 2 works
- 8 Radiation Therapy and Dosimetry Pulmonary and Respiratory Medicine 2 works
- 9 Advances in Oncology and Radiotherapy Radiology, Nuclear Medicine and Imaging 1 works
- 10 Ovarian cancer diagnosis and treatment Reproductive Medicine 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Novocure (United States)'s research output changed?
Output in 2018–2022 was 264% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Portsmouth
- Portsmouth Regional Hospital
- RMC Research (United States)
- Northeastern Regional Association of Coastal and Ocean Observing Systems (United States)
- Strawbery Banke Museum
- HBLA (United States)
- Gundalow (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.